Fundamentals of Clinical Psychopharmacology
Fundamentals of Clinical Psychopharmacology provides up-to-date, evidence-based and unbiased information about psychopharmacology. It spans the range of the discipline, from mode of action and side effects of drugs to meta-analyses of clinical trials. It is anchored to practice guidelines produced by the UK National Institute for Health and Care Excellence (NICE) and the British Association for Psychopharmacology (BAP). Care has been taken to provide an international perspective that makes it equally useful to practitioners in the US and other countries.
The book grew out of BAP courses that set the standard for professional psychopharmacological education in the UK. This latest edition is fully updated and provides, in a concise and easy-to-read format, key facts about currently used psychotropic drugs, set in the context of the neuroscience of the disorders they treat. It also includes a new chapter on the principles of psychiatric prescribing.
Key references, including the clinical studies discussed, are provided at the end of the chapter along with suggestions for further reading. Intended to be a frequently updated, affordable, concise and practical resource, it meets the needs of trainees and practitioners seeking to keep abreast of the state of the art in psychopharmacology.
August 18, 2015 by CRC Press
Reference - 280 Pages - 42 Color Illustrations
ISBN 9781498718943 - CAT# K25477
- Delivers the cutting edge, up-to-date and accessible new edition
- Draws the knowledge of the top UK psychopharmacologists
- Discusses drugs licensed worldwide
- Contains material endorsed by the British Association for Psychopharmacology
- Covers the long-running BAP course
Table of Contents
Neuropharmacology and Drug Action
Sarah E. Gartside and Charles A. Marsden
Pharmacokinetics and Pharmacodynamics
Ian M. Anderson
Frances Cheng, Peter B. Jones and Peter S. Talbot
Antidepressants and ECT
Chris Smart, Ian M. Anderson and R. Hamish McAllister-Williams
‘Mood Stabilisers’ and Other Treatments for Bipolar Disorder
Allan H. Young and Sarah C. Wooderson
Anxiolytic and Hypnotic Drugs
David S. Baldwin and Nupur Tiwari
Drugs of Abuse
Anne Lingford-Hughes and Mark Daglish
Drugs for Dementia and Cognitive Impairment
Mehran Javeed, Ian M. Anderson and Iracema Leroi
Drugs Used for Personality Disorders and Behavioural Disturbance
Birgit A. Völlm and Ian M. Anderson
Drug Treatments for Child and Adolescent Disorders
David R. Coghill
Prescribing in Clinical Practice
Peter M. Haddad and Angelika Wieck
Clinical Trial Methodology
Stephen M. Lawrie and R. Hamish McAllister-Williams
Ian M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP.
R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.
"This is an excellent resource that is easy to read, succinct but complete, and is based solely on research findings. I have read many psychopharmacology books, but this is one of the best because of how well it compiles a vast amount of information in short chapters. While the chapters about specific medications and conditions are well written, the chapters on research and basic prescribing practices are exceptional and complement the other chapters."
—Aaron Plattner, MD, Doody’s Book Reviews